Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
A mining company has announced plans to extract 10,000 tonnes of lithium a year from rocks beneath a County Durham beauty spot after drilling found vast volumes of hot brines laden with the precious mineral.
Lithium is an essential component of the rechargeable batteries that power everything from mobile phones to electric vehicles – but the UK is currently entirely dependent on imports.
Weardale Lithium’s planned processing plant in the Co Durham valley would strip the lithium from water pumped from deep underground reservoirs, creating the UK’s first domestic supply of the mineral.
If the deposits prove commercially viable then the UK could reduce its current complete reliance on imports which mainly come from Australia and South America.
The area is the second part of the UK to yield commercially viable lithium deposits. Cornish Lithium is already seeking to exploit similar deposits in Cornwall. It too expects to produce about 10,000 tonnes a year.
Stewart Dickson, the chief executive of Weardale Lithium, said the company wanted to establish “a facility for domestic lithium production from naturally occurring geothermal groundwaters that would become a focal point for the UK lithium industry.”
Weardale Valley is a renowned beauty spot on the east side of the Pennines, about 19 miles long but with a long history of mining, mainly for lead, silver and fluorspar.
The hot lithium-rich brines were discovered after boreholes were drilled more than 3,500 feet into the rocks underlying Weardale.
Under the scheme, the heat from the water could be used to warm local homes and businesses with the water also processed to remove lithium, before being pumped back underground.
Advertisement
By 2030, the UK is expected to require 80,000 tonnes of lithium carbonate a year for electric car batteries and renewable energy storage. It can be produced from mining and processing the lithium-rich rocks found in Australia, Brazil and Zimbabwe but this is energy-intensive and expensive.
Lithium often appears in brines and brine deposits – with vast deposits extracted this way in Chile, Argentina and Bolivia.
The mineral has long been used for making heat-resistant glass, lubricants and industrial steel production but demand now is driven by its use in rechargeable batteries for anything from mobile phones to electric cars.
Weardale Lithium said that, if approved by Durham County Council’s planning committee, its processing plant would be “one of the most advanced lithium extraction plants in Europe.”
Odd that it’s blue on sells
Still here MO
It’s a buy
Also…
Astra Zeneca’s most profitable drug at the moment is Farxiga. https://www.biospace.com/article/astrazeneca-sees-6-percent-revenue-growth-in-2023-despite-plummeting-covid-19-sales/. They made nearly 6 Billion US Dollars last year from Farxiga, as used to treat Chronic Kidney Disease (CKD) and Diabetes. They are thus VERY keen to see screening for CKD increased. https://www.fiercepharma.com/marketing/astrazeneca-decries-low-kidney-disease-diagnosis-rates-finds-urgent-need-better-screening
Https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.15273?af=R
Conclusions
Using two independent cohorts and a clinical trial population, we validated an updated KidneyIntelX test (named kidneyintelX.dkd), which significantly enhanced risk stratification in patients with DKD for PDKF, independently from known risk factors for progression.
Interestingly...
CONFLICT OF INTEREST STATEMENT
Girish N. Nadkarni reports consultancy agreements with AstraZeneca, BioVie, GLG Consulting, Pensieve Health, Reata, Renalytix, Siemens Healthineers, G.S.K Pharma and Variant Bio, research funding from Goldfinch Bio and Renalytix, honoraria from AstraZeneca, BioVie, Lexicon and Reata, and patents or royalties for Renalytix, owns equity and stock options in Pensieve Health as a cofounder and in Renalytix, has received financial compensation as a scientific board member and advisor to Renalytix, serves on the advisory board of Neurona Health, and serves in an advisory or leadership role for Pensieve Health and Renalytix.
It’s got to be AstraZeneca
It’s AstraZeneca surely? They’ve been collaborating for years.
Up 40% over there pre market $RNLX https://www.nasdaq.com/market-activity/stocks/rnlx/pre-market
Https://www.voxmarkets.co.uk/rns/announcement/8546954d-e61a-4c75-a80c-8c95097fbfa5/
@Hermes_Paris @LouisVuitton and @Dior all have form when it comes to faux leather. Only those three have the MC mentioned according to the chatter. Any of them will do just fine. #BSFA. See you at 50p.
Interesting read https://www.euronews.com/culture/2024/01/22/is-fashion-ready-to-say-goodbye-to-leather?utm_source=Twitter&utm_medium=Social
They’re not. Main market so no nomad.
Https://www.lse.co.uk/rns/DKE/result-of-agm-tx28ui6pxd5lf8b.html
Dated: 8 January 2024
Mast Energy Developments PLC ('MED' or 'the Company')
MED Binding Joint Venture Agreement Progress Update
Mast Energy Developments PLC, the UK-based multi-asset owner, developer and operator in the rapidly growing flexible power market, announces that further to its previous announcement dated 2 January 2024, Proventure has still not made the first £1m payment to the Project SPV, which MED now understands was delayed due to a lack of coordination and administrative difficulties on the side of Proventure over the festive holiday period. Proventure CEO, Mr. Kona will be travelling to London soon, in order to work with the MED CEO and board to expedite delivery of the overdue JVA investment payments, as well as to finalise the outstanding administration to complete the JVA transaction.
The Company will provide a further update as soon as possible on the outcome of the deliberations referred to above.
The Company is furthermore in advanced discussions in respect of an alternative source of short-term funding to ensure that any further delays regarding the JVA will not unduly impact the Company's ability to meet its working capital requirements.
Pieter Krügel, MED CEO, commented: "The past year has proven exceptionally challenging for MED, not only from a macro-economic perspective affecting most businesses globally, but also from a transactional perspective. However, we are looking forward to the new year to realise MED's plans and potential, and we sincerely thank our shareholders and key stakeholders for their ongoing patience and support."
ENDS
Any HL holders had their stock yet? Might be worth giving them a call today.
Yeah but that guy owns both
Srinivaskona@proventuregroup.com - have emailed assuming it's all related
https://www.indiafilings.com/search/proventure-holdings-india-private-limited-cin-U67100TG2021PTC149472#:~:text=PROVENTURE%20HOLDINGS%20INDIA%20PRIVATE%20LIMITED%20is%20a%20Private%20Limited%20Company,s)%20of%20the%20company%20viz.
https://find-and-update.company-information.service.gov.uk/company/12723680/officers
Https://fintel.io/doc/sec-spectral-ai-inc-1833498-8k-2023-december-27-19718-336